Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Directa Plus PLC gets G+ green light from toxicity testing firm

This latest decision complements previous tests conducted by Complife (then operating as Farcoderm) on all of Directa Plus's graphene-based materials, which were certified as safe for human contact
Skin irritation
It's what you might call a rash decision, but in a positive way

Directa Plus Plc (LON:DCTA) said its Graphene Plus (G+) membrane and G+ printed fabrics have received international certification from Complife Italia.

Complife, an independent toxicity testing organisation, confirmed that the materials do not cause any irritation to human skin.

READ: Directa Plus inks high performance textiles deal with Alfredo Grassi

"We are pleased to have our G+ membrane and printed fabrics proven to be non-irritating to human skin. This adds to the certification we received last year that our graphene-based materials are non-toxic and non-cytotoxic,” said Giulio Cesareo, chief ececutive officer of Directa Plus.

“With our Graphene Plus textiles, our customers can truly differentiate their products as innovative, performance-enhancing and comfortable to wear. We have always prided ourselves on the safety and environmental credentials of our production processes and graphene-based products, and this new certification further represents that commitment," he added.

WATCH: Directa Plus hires heavy-hitting new head of sales

Shares in Directa Plus were up 0.5% in early trading.

View full DCTA profile View Profile

Directa Plus Plc Timeline

Related Articles

Italian police
July 09 2018
Founded 12 years ago, its aim is to design a system to produce graphene in a “sustainable, simple and a scalable way”

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use